These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9096988)
21. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates. van Bon AC; Dragt D; DeVries JH Diabetes Technol Ther; 2012 May; 14(5):447-8. PubMed ID: 22548715 [No Abstract] [Full Text] [Related]
22. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group. Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967 [TBL] [Abstract][Full Text] [Related]
24. Programmable implantable insulin infusion devices and diabetes care. Charles MA Diabetes Technol Ther; 1999; 1(1):89-96. PubMed ID: 11475311 [No Abstract] [Full Text] [Related]
25. A preliminary trial of the programmable implantable medication system for insulin delivery. Saudek CD; Selam JL; Pitt HA; Waxman K; Rubio M; Jeandidier N; Turner D; Fischell RE; Charles MA N Engl J Med; 1989 Aug; 321(9):574-9. PubMed ID: 2761602 [TBL] [Abstract][Full Text] [Related]
26. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion. Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865 [TBL] [Abstract][Full Text] [Related]
27. Cecum erosion: unusual but serious complication of an implanted catheter for peritoneal insulin delivery. Renard E; Taourel P; Quenet F; Domergue J; Bruel JM; Bringer J Diabetes Care; 1995 Mar; 18(3):408-9. PubMed ID: 7555488 [No Abstract] [Full Text] [Related]
28. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Renard E; Guerci B; Leguerrier AM; Boizel R; Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682 [TBL] [Abstract][Full Text] [Related]
29. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia. Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227 [TBL] [Abstract][Full Text] [Related]
30. Utilization of an elastomeric continuous infusion device to maintain catheter patency. Heath J; Jones S J Intraven Nurs; 2001; 24(2):102-6. PubMed ID: 11836834 [TBL] [Abstract][Full Text] [Related]
31. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group. Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802 [TBL] [Abstract][Full Text] [Related]
32. A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy. Morris M; Phares K; Zaccardelli D; Ujhelyi MR J Vasc Access; 2008; 9(1):20-7. PubMed ID: 18379976 [TBL] [Abstract][Full Text] [Related]
33. Successful pregnancy in I.D.D.M. with intravenous programmable insulin pump. Brosnan E; Devlin JG Ir J Med Sci; 1994 Feb; 163(2):56-7. PubMed ID: 8200770 [TBL] [Abstract][Full Text] [Related]
34. Side effects and indwelling times of subcutaneous catheters for insulin injections: a new device for injecting insulin with a minimum of pain in the treatment of insulin-dependent diabetes mellitus. Hanas R; Ludvigsson J Diabetes Res Clin Pract; 1990; 10(1):73-83. PubMed ID: 2249606 [TBL] [Abstract][Full Text] [Related]
35. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Hoogma RP; Schumicki D Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727 [TBL] [Abstract][Full Text] [Related]